Evidence map›Paper›PMID 27529220›Full record

ArticleInternational journal of molecular sciences2016

Urinary Metabolic Phenotyping Reveals Differences in the Metabolic Status of Healthy and Inflammatory Bowel Disease (IBD) Children in Relation to Growth and Disease Activity.

Francois-Pierre Martin, Jessica Ezri, Ornella Cominetti, Laeticia Da Silva, Martin Kussmann, Jean-Philippe Godin, Andreas Nydegger

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Emerging concepts in non-invasive monitoring of Crohn's disease.Therapeutic advances in gastroenterology · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Francois-Pierre MartinNestlé Institute of Health Sciences, 1015 Lausanne, Switzerland. francois-pierre.martin@rd.nestle.com.
Jessica EzriDivision of Pediatric Gastroenterology, University of Lausanne, 1011 Lausanne, Switzerland. jessica.ezri@chuv.ch.
Ornella CominettiNestlé Institute of Health Sciences, 1015 Lausanne, Switzerland. ornella.cominetti@rd.nestle.com.
Laeticia Da SilvaNestlé Institute of Health Sciences, 1015 Lausanne, Switzerland. Laeticia.DaSilva@rd.nestle.com.
Martin KussmannNestlé Institute of Health Sciences, 1015 Lausanne, Switzerland. Martin.Kussmann@rd.nestle.com.
Jean-Philippe GodinNestlé Research Center, 1000 Lausanne, Switzerland. jean-philippe.godin@rdls.nestle.com.
Andreas NydeggerDivision of Pediatric Gastroenterology, University of Lausanne, 1011 Lausanne, Switzerland. andreas.nydegger@chuv.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGrowth failure and delayed puberty are well known features of children and adolescents with inflammatory bowel disease (IBD), in addition to the chronic course of the disease. Urinary metabonomics was applied in order to better understand metabolic changes between healthy and IBD children.

methods21 Pediatric patients with IBD (mean age 14.8 years, 8 males) were enrolled from the Pediatric Gastroenterology Outpatient Clinic over two years. Clinical and biological data were collected at baseline, 6, and 12 months. 27 healthy children (mean age 12.9 years, 16 males) were assessed at baseline. Urine samples were collected at each visit and subjected to ¹H Nuclear Magnetic Resonance (NMR) spectroscopy.

resultsUsing ¹H NMR metabonomics, we determined that urine metabolic profiles of IBD children differ significantly from healthy controls. Metabolic differences include central energy metabolism, amino acid, and gut microbial metabolic pathways. The analysis described that combined urinary urea and phenylacetylglutamine-two readouts of nitrogen metabolism-may be relevant to monitor metabolic status in the course of disease.

conclusionNon-invasive sampling of urine followed by metabonomic profiling can elucidate and monitor the metabolic status of children in relation to disease status. Further developments of omic-approaches in pediatric research might deliver novel nutritional and metabolic hypotheses.

Indexed as

AdolescentChildColitis, UlcerativeCrohn DiseaseFemaleHumansInflammatory Bowel DiseasesMagnetic Resonance SpectroscopyMaleMetabolomicsCrohn’s diseasegrowthinflammatory bowel diseasemetabolismpediatricphenotypeulcerative colitis

Identifiers

PMID27529220
PMCPMC5000707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.